The number of Americans recommended for statins ballooned from 13 million to 56 million due to progressively lowered cholesterol thresholds. The expert committees setting these guidelines often had members with financial ties to drug makers, creating a conflict of interest.

Top preventative cardiologists privately advise their own families to get a CAC scan at age 30-35. If the score is non-zero, they prescribe statins to get LDL cholesterol below 40—less than half the standard 'green zone' level. This reveals a significant gap between public guidelines and the aggressive preventative strategies used by experts for their loved ones.

Widespread adoption of preventive health measures faces a major political hurdle. Politicians on four-year election cycles are incentivized to fund programs with immediate effects, rather than long-term prevention initiatives that may take 20-30 years to show results.

The medical establishment's fear of lawsuits over acute events (like a fatal low blood sugar incident) leads to diabetes management strategies that prevent short-term disasters but allow long-term, debilitating complications like blindness. This incentive misalignment suppresses simpler, more effective dietary solutions that could improve quality of life.

A pragmatic approach to heart screening is to use the cheap, non-invasive Calcium CT (CAC) scan as a first-line filter. If the result is zero, further testing may be unnecessary. A non-zero score, indicating a propensity to build plaque, then justifies the more invasive and expensive ($2,000+) angiogram to assess soft plaques and blockage levels. This tiered strategy makes advanced screening accessible and cost-effective.

High healthcare costs are not an inherent failure of capitalism but a result of regulatory capture. Established companies influence legislation to create immense barriers to entry, stifling innovation from new competitors, which leads to ballooning administrative costs instead of more physicians and better care.

Standard cholesterol tests are poor predictors of heart attacks, as 50% of victims fall within the 'normal' range. This reliance on an incomplete metric means millions of people, including those with healthy lifestyles, may have a false sense of security about their heart health, overlooking the more definitive presence of arterial plaque.

The healthcare system is fundamentally reactive, designed to intervene after a failure like a disease or injury. It overlooks the gradual decline in functional capability that precedes these events, creating a massive blind spot in preventive health for the general population.

Relying on blood lipid panels (LDL, etc.) to assess cardiovascular risk is misleading, as they don't confirm arterial plaque. A CT angiography (CCTA), like a Cleerly scan, provides direct imaging of both hard and soft plaque, offering a far more accurate assessment of actual heart disease risk.